Thomson Scientific Announces BONDplus for Biological R...( Life Science Platform Delivers Real T...),Health

Life Science Platform Delivers Real Time, Comprehensive and Seamless Public and Proprietary Biological Sequence, Interaction and Patent Information

PHILADELPHIA, Sept. 10 /PRNewswire-FirstCall/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, announced today the release of BONDplus, an integrated, web-based data platform to address the information and analytic needs of biological researchers.

Compiled from 15 assembled resources including GenBank, RefSeq, Entrez Gene and UniProtKB/Swiss-Prot, BONDplus allows researchers to move beyond the genome and leverage publicly available biological sequence data, BINDplus biomolecular interaction data as well as GENESEQ, a value added database of patented biological sequences. The platform allows novel insights into biological research including target-based discovery and rational drug design.

"Today's life science data management faces considerable hurdles due to years of fragmented and non-standardized production of biological data," said Jon Brett-Harris, executive vice president of pharmaceutical and chemical markets at Thomson Scientific. "Since solutions are frequently focused on one data type or in a niche area, an integrated platform can provide a distinct competitive advantage, allowing scientists not only to access public domain data, but also to integrate their own proprietary data and value-added Thomson Scientific data in a consistent and user-friendly format."

BONDplus provides an intuitive and value-added resource for any researcher by uniting the genomic, proteomic and metabolomic research communities around one compr
'/>"/>